{"id":84823,"date":"2025-09-08T11:33:56","date_gmt":"2025-09-08T16:33:56","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?p=84823"},"modified":"2025-10-02T07:25:50","modified_gmt":"2025-10-02T12:25:50","slug":"prise-en-charge-du-diabete-insipide-di","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/fr\/managing-diabetes-insipidus-di\/","title":{"rendered":"Prise en charge du diab\u00e8te insipide (DI)"},"content":{"rendered":"<p><iframe loading=\"lazy\" title=\"Prise en charge du diab\u00e8te insipide (AVP-D) : conseils pratiques d&#039;un patient-expert\" width=\"1080\" height=\"608\" src=\"https:\/\/www.youtube.com\/embed\/qash_2MFo1Q?feature=oembed\"  allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<p>Pat Gildroy, administratrice principale du groupe Facebook \u201c Got Arginine VasoPressin Deficiency ? \u201d, parle des ressources disponibles, des sympt\u00f4mes, des examens m\u00e9dicaux et du quotidien des personnes atteintes d'un d\u00e9ficit en arginine vasopressine, anciennement appel\u00e9 \u00ab diab\u00e8te insipide \u00bb.<\/p>","protected":false},"excerpt":{"rendered":"<p>Prise en charge du diab\u00e8te insipide (DI), d\u00e9sormais appel\u00e9e \u00ab d\u00e9ficit en arginine-vasopressine \u00bb (AVP-D), rev\u00eat une importance cruciale pour les patients, leurs familles et les cliniciens \u2014 en particulier chez les personnes atteintes de la maladie d\u2019Erdheim-Chester (ECD) ou d\u2019histiocytose \u00e0 cellules de Langerhans (LCH), pathologies dans lesquelles l\u2019AVP-D est plus fr\u00e9quente.<\/p>","protected":false},"author":20,"featured_media":92893,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"yes","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[351],"tags":[4256,4750,4752,387,374,2261,4251,102,4751,4258,2398,4257,4255,4254,4253],"class_list":["post-84823","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-webinar-recordings","tag-clinicaltranslation","tag-diabetes","tag-diabetesinsipidus","tag-ecdga","tag-erdheimchesterdisease","tag-globalhealth","tag-grantopportunity","tag-histiocytosis","tag-insipidus","tag-medicalinnovation","tag-medicalresearch","tag-oncologyresearch","tag-patientregistry","tag-rarediseaseresearch","tag-scientificcollaboration"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/posts\/84823","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/comments?post=84823"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/posts\/84823\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/media\/92893"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/media?parent=84823"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/categories?post=84823"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/fr\/wp-json\/wp\/v2\/tags?post=84823"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}